200 related articles for article (PubMed ID: 7404127)
1. In vitro neutralizing capacity of commercially available antacid mixtures, and their role in the treatment of peptic ulcer.
Clain JE; Wright JP; Price RN; Marks IN
S Afr Med J; 1980 Feb; 57(5):158-60. PubMed ID: 7404127
[TBL] [Abstract][Full Text] [Related]
2. [Theoretical and clinical aspects of the antacid therapy].
Ruppin H
Med Klin; 1975 Jul; 70(30):1237-42. PubMed ID: 1097880
[No Abstract] [Full Text] [Related]
3. Antacids in the treatment of peptic ulcer disease.
Garrigues-Gil V
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():73-7. PubMed ID: 2657291
[TBL] [Abstract][Full Text] [Related]
4. Methods for the assessment of antacids. In-vitro and in-vivo investigations with gastric aspiration.
Keyriläinen O
Scand J Gastroenterol Suppl; 1982; 75():40-3. PubMed ID: 6959249
[TBL] [Abstract][Full Text] [Related]
5. [Lattice structure antacids and antacid mixtures].
Miederer SE; Schmidt C
Z Gastroenterol; 1987 Aug; 25 Suppl 3():130-5. PubMed ID: 3660893
[TBL] [Abstract][Full Text] [Related]
6. [Thr role of antacids in modern ulcer therapy].
Blum AL
Dtsch Med Wochenschr; 1985 Jan; 110(1):3-7. PubMed ID: 3965280
[No Abstract] [Full Text] [Related]
7. [Therapy with antacids].
Holtermüller KH
Fortschr Med; 1979 Jun; 97(23):1068-71, 1087. PubMed ID: 37146
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology and clinical use of antacids.
Green FW; Norton RA; Kaplan MM
Am J Hosp Pharm; 1975 Apr; 32(4):425-9. PubMed ID: 236651
[TBL] [Abstract][Full Text] [Related]
9. [Antacid therapy of peptic ulcer].
Fisher AA
Klin Med (Mosk); 1969 Apr; 47(4):43-8. PubMed ID: 5371486
[No Abstract] [Full Text] [Related]
10. [Evaluation of the neutralizing capacity in vitro of some typified antacid preparations].
Pastia A; Caba M; Gafiţanu E; Matei I
Rev Med Chir Soc Med Nat Iasi; 1978; 82(1):123-5. PubMed ID: 674940
[No Abstract] [Full Text] [Related]
11. Extended neutralization of gastric contents with Ducon.
Riegel N; Tesler MA; Zimmon DS; Jolly ER
Am J Dig Dis; 1974 Apr; 19(4):335-7. PubMed ID: 4595261
[No Abstract] [Full Text] [Related]
12. [Antacids and antipeptic agents].
Belousov AS; Mamedova LD; Zel'din VE; Rakitskaia LG; Loranskaia ID
Klin Med (Mosk); 1989 Sep; 67(9):123-9. PubMed ID: 2511377
[No Abstract] [Full Text] [Related]
13. New aspects of clinical pharmacology of antacids.
Konturek SJ
J Physiol Pharmacol; 1993 Sep; 44(3 Suppl 1):5-21. PubMed ID: 8260735
[TBL] [Abstract][Full Text] [Related]
14. [Medical treatment of bleeding ulcers: the effects of antacid neutralization of pH 7 of gastric juice].
Hostein J; Fournet J; Meullenet J; Bonnet-Eymard J
Gastroenterol Clin Biol; 1982; 6(8-9):638-45. PubMed ID: 6751922
[No Abstract] [Full Text] [Related]
15. The effect of combined antacid-anticholinergic treatment on the intragastric pH in peptic ulcer disease.
Marcussen JM; Vilsvik JS
Scand J Gastroenterol; 1968; 3(2):170-6. PubMed ID: 5711480
[No Abstract] [Full Text] [Related]
16. [In vitro determination of the neutralizing capacity of antacids].
Brunner H
Z Gastroenterol; 1983 Mar; 21 Suppl():22-5. PubMed ID: 6858407
[TBL] [Abstract][Full Text] [Related]
17. [Medical treatment of peptic ulcer].
Meeroff JC; Meeroff M
Rev Esp Enferm Apar Dig; 1977 Feb; 49(2):251-84. PubMed ID: 319516
[No Abstract] [Full Text] [Related]
18. Antacid pharmacology in duodenal ulcer. Effect of antacids on postcibal gastric acidity and peptic activity.
Fordtran JS; Collyns JA
N Engl J Med; 1966 Apr; 274(17):921-7. PubMed ID: 5908884
[No Abstract] [Full Text] [Related]
19. [Length of effectiveness of calcium-containing and calcium-free antacids. A double-blind study].
Weingart J; Haase W; Ottenjann R
Fortschr Med; 1977 Nov; 95(44):2681-4. PubMed ID: 21837
[TBL] [Abstract][Full Text] [Related]
20. Effect of a new antacid on basal and meal-stimulated gastric secretion.
Sun DC; Rider JA
Am J Gastroenterol; 1978 Mar; 69(3 Pt 1):283-8. PubMed ID: 27093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
